Nallasamy, Palanisamy
Nimmakayala, Rama Krishna
Parte, Seema
Are, Abhirup C.
Batra, Surinder K.
Ponnusamy, Moorthy P.
Article History
Received: 22 May 2022
Accepted: 16 November 2022
First Online: 22 December 2022
Declarations
:
: Not applicable.
: All authors agree with the content and consent to publication of Molecular Cancer journal.
: SKB is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc. The other authors disclosed no potential conflicts of interest.